Prescryptive Health, Lilly partner on first-to-market value-based program to stabilize insulin pricing
The new financial model aims to provide price transparency while encouraging medication adherence.
Partners offer app compatibility with Tempo Pen and Tempo Smart Button to help streamline diabetes management.
The two companies will collaborate to create a new version of the BlueStar insulin management solution that integrates insulin data for Lilly insulins.
The early-stage study took place over 12 weeks and included an 82-person healthy control group and 31 individuals with varying stages of cognitive decline.